PMC:7795856 / 4009-4200 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"116","span":{"begin":19,"end":22},"obj":"Gene"},{"id":"117","span":{"begin":73,"end":79},"obj":"Gene"},{"id":"118","span":{"begin":152,"end":155},"obj":"Gene"},{"id":"131","span":{"begin":59,"end":69},"obj":"Chemical"},{"id":"132","span":{"begin":111,"end":121},"obj":"Chemical"}],"attributes":[{"id":"A116","pred":"tao:has_database_id","subj":"116","obj":"Gene:134864"},{"id":"A117","pred":"tao:has_database_id","subj":"117","obj":"Gene:1493"},{"id":"A118","pred":"tao:has_database_id","subj":"118","obj":"Gene:20539"},{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"MESH:D000074324"},{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"MESH:D000074324"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"iving sequentially Tα1 and the immune checkpoint inhibitor ipilimumab, a CTLA-4-blocking antibody, compared to ipilimumab therapy alone [16]. Moreover, Tα1 was shown to prevent intestinal tox"}